MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PCRX has $1,264,917K in assets. $571,806K in debts. $158,545K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
454.41%
Quick Ratio
327.65%
Cash Ratio
131.47%
Debt to Asset Ratio
45.21%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable, net
    • Deferred tax assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Long-term debt, net
    • Accumulated deficit
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
158,545
Short-term available-for-sale investments
79,879
Accounts receivable, net
124,069
Inventories, net
152,863
Prepaid expenses and other current assets
32,618
Total current assets
547,974
Fixed assets, net
140,690
Right-of-use assets, net
41,777
Goodwill
20,214
Intangible assets, net
368,100
Deferred tax assets
123,854
Investments and other assets
22,308
Total assets
1,264,917
Accounts payable
15,150
Accrued expenses
95,601
Lease liabilities
9,839
Current portion of long-term debt, net
0
Total current liabilities
120,590
Long-term debt, net
372,189
Lease liabilities
36,176
Contingent consideration
18,066
Deferred tax liabilities
4,213
Other liabilities
20,572
Total liabilities
571,806
Common stock, par value 0.001 250,000,000 shares authorized 47,890,777 shares issued and 41,116,739 shares outstanding at december31, 2025 and 47,077,844 shares issued and 46,240,604 shares outstanding at december31, 2024
48
Treasury stock, at cost, inclusive of excise tax and broker fees, 6,774,038 and 837,240 shares at december31, 2025 and 2024, respectively
176,565
Additional paid-in capital
1,064,623
Accumulated deficit
-199,322
Accumulated other comprehensive income
4,327
Total stockholders equity
693,111
Total liabilities and stockholders equity
1,264,917
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$158,545K Inventories, net$152,863K Accounts receivable, net$124,069K Short-termavailable-for-sale investments$79,879K Prepaid expenses andother current assets$32,618K Total current assets$547,974K Intangible assets, net$368,100K Fixed assets, net$140,690K Deferred tax assets$123,854K Right-of-use assets, net$41,777K Investments and other assets$22,308K Goodwill$20,214K Total assets$1,264,917K Total liabilities andstockholders equity$1,264,917K Total stockholdersequity$693,111K Total liabilities$571,806K Accumulated deficit-$199,322K Treasury stock, at cost,inclusive of excise tax and...$176,565K Additional paid-in capital$1,064,623K Long-term debt, net$372,189K Total currentliabilities$120,590K Lease liabilities$36,176K Other liabilities$20,572K Contingent consideration$18,066K Deferred tax liabilities$4,213K Accumulated othercomprehensive income$4,327K Common stock, par value0.001 250,000,000...$48K Accrued expenses$95,601K Accounts payable$15,150K Lease liabilities$9,839K

Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences, Inc. (PCRX)